$548 Million is the total value of Ikarian Capital, LLC's 139 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 67.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ALNY | Buy | ALNYLAM PHARMACEUTICALS INCcall | $42,486,000 | +92.4% | 291,300 | +115.5% | 7.75% | +166.9% |
XBI | New | SPDR SER TRput | $25,994,000 | – | 350,000 | +100.0% | 4.74% | – |
AMGN | AMGEN INCcall | $24,330,000 | +0.6% | 100,000 | 0.0% | 4.44% | +39.5% | |
BIIB | BIOGEN INCcall | $22,880,000 | -3.2% | 112,200 | 0.0% | 4.17% | +34.3% | |
AXSM | New | AXSOME THERAPEUTICS INCput | $19,151,000 | – | 500,000 | +100.0% | 3.49% | – |
CLDX | Buy | CELLDEX THERAPEUTICS INC NEWput | $16,628,000 | -18.0% | 616,700 | +3.6% | 3.03% | +13.7% |
CLDX | CELLDEX THERAPEUTICS INC NEW | $14,504,000 | -20.8% | 537,958 | 0.0% | 2.64% | +9.8% | |
CLDX | Buy | CELLDEX THERAPEUTICS INC NEWcall | $13,656,000 | +16.5% | 506,500 | +47.2% | 2.49% | +61.6% |
AXSM | New | AXSOME THERAPEUTICS INCcall | $13,404,000 | – | 350,000 | +100.0% | 2.44% | – |
ESPR | New | ESPERION THERAPEUTICS INC NE | $13,067,000 | – | 2,054,602 | +100.0% | 2.38% | – |
HZNP | Buy | HORIZON THERAPEUTICS PUB L | $12,771,000 | +10.2% | 160,116 | +45.4% | 2.33% | +52.9% |
KRTX | Buy | KARUNA THERAPEUTICS INC | $12,651,000 | +99.5% | 100,000 | +100.0% | 2.31% | +176.6% |
KRTX | New | KARUNA THERAPEUTICS INCput | $12,652,000 | – | 100,000 | +100.0% | 2.31% | – |
KZR | Buy | KEZAR LIFE SCIENCES INC | $11,645,000 | -35.3% | 1,408,116 | +30.0% | 2.12% | -10.3% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $11,271,000 | +72.8% | 40,000 | +60.0% | 2.06% | +139.5% |
ALT | New | ALTIMMUNE INC | $10,499,000 | – | 897,359 | +100.0% | 1.91% | – |
UTHR | New | UNITED THERAPEUTICS CORP DEL | $9,426,000 | – | 40,000 | +100.0% | 1.72% | – |
BLU | Buy | BELLUS HEALTH INC NEW | $9,409,000 | +49.8% | 1,018,327 | +11.5% | 1.72% | +107.7% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $8,931,000 | +4343.3% | 61,237 | +4850.4% | 1.63% | +6161.5% |
KZR | Buy | KEZAR LIFE SCIENCES INCcall | $8,894,000 | +90.6% | 1,075,300 | +282.9% | 1.62% | +164.2% |
BMRN | Sell | BIOMARIN PHARMACEUTICAL INCcall | $8,843,000 | -63.4% | 106,700 | -66.0% | 1.61% | -49.3% |
GOSS | Buy | GOSSAMER BIO INC | $8,373,000 | +24.4% | 1,000,387 | +29.0% | 1.53% | +72.5% |
MIST | Sell | MILESTONE PHARMACEUTICALS IN | $8,194,000 | -33.8% | 1,379,422 | -28.5% | 1.49% | -8.2% |
SAGE | SAGE THERAPEUTICS INCcall | $8,075,000 | -2.4% | 250,000 | 0.0% | 1.47% | +35.3% | |
HZNP | Sell | HORIZON THERAPEUTICS PUB Lcall | $7,976,000 | -52.0% | 100,000 | -36.7% | 1.45% | -33.5% |
SRPT | New | SAREPTA THERAPEUTICS INCcall | $7,495,000 | – | 100,000 | +100.0% | 1.37% | – |
XENE | XENON PHARMACEUTICALS INC | $7,283,000 | -0.5% | 239,441 | 0.0% | 1.33% | +37.9% | |
Buy | AMYLYX PHARMACEUTICALS INCcall | $6,757,000 | +110.3% | 350,800 | +40.3% | 1.23% | +191.3% | |
LNTH | New | LANTHEUS HLDGS INCcall | $6,602,000 | – | 100,000 | +100.0% | 1.20% | – |
ALNY | Sell | ALNYLAM PHARMACEUTICALS INCput | $5,820,000 | -69.7% | 39,900 | -66.1% | 1.06% | -58.0% |
RLMD | New | RELMADA THERAPEUTICS INCcall | $5,698,000 | – | 300,000 | +100.0% | 1.04% | – |
TCON | Sell | TRACON PHARMACEUTICALS INC | $5,577,000 | -25.4% | 2,788,853 | -1.9% | 1.02% | +3.5% |
APLS | Sell | APELLIS PHARMACEUTICALS INCcall | $5,572,000 | -37.4% | 123,200 | -29.6% | 1.02% | -13.2% |
RLMD | New | RELMADA THERAPEUTICS INCput | $5,362,000 | – | 282,300 | +100.0% | 0.98% | – |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $4,972,000 | +28.9% | 60,000 | +20.0% | 0.91% | +78.9% |
RETA | Buy | REATA PHARMACEUTICALS INCcall | $4,923,000 | +880.7% | 162,000 | +958.8% | 0.90% | +1260.6% |
PCVX | Sell | VAXCYTE INC | $4,918,000 | -35.5% | 225,991 | -28.5% | 0.90% | -10.6% |
ICPT | New | INTERCEPT PHARMACEUTICALS INcall | $4,832,000 | – | 350,000 | +100.0% | 0.88% | – |
GLPG | GALAPAGOS NVspon adr | $4,830,000 | -10.8% | 86,865 | 0.0% | 0.88% | +23.7% | |
Sell | AMYLYX PHARMACEUTICALS INC | $4,750,000 | -6.8% | 246,554 | -37.8% | 0.87% | +29.3% | |
SCPH | Sell | SCPHARMACEUTICALS INC | $4,261,000 | -22.7% | 884,008 | -8.9% | 0.78% | +7.2% |
HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $4,196,000 | – | 86,035 | +100.0% | 0.76% | – |
PFE | PFIZER INC | $4,194,000 | +1.3% | 80,000 | 0.0% | 0.76% | +40.4% | |
NBIX | New | NEUROCRINE BIOSCIENCES INC | $3,763,000 | – | 38,600 | +100.0% | 0.69% | – |
ALT | New | ALTIMMUNE INCcall | $3,553,000 | – | 303,600 | +100.0% | 0.65% | – |
VRDN | New | VIRIDIAN THERAPEUTICS INCcall | $3,472,000 | – | 300,000 | +100.0% | 0.63% | – |
KWEB | New | KRANESHARES TRcsi chi internet | $3,277,000 | – | 100,000 | +100.0% | 0.60% | – |
BPMC | BLUEPRINT MEDICINES CORPcall | $3,232,000 | -20.9% | 64,000 | 0.0% | 0.59% | +9.5% | |
GOSS | Buy | GOSSAMER BIO INCcall | $2,800,000 | +52.5% | 334,500 | +58.1% | 0.51% | +112.0% |
STSA | SATSUMA PHARMACEUTICALS INC | $2,704,000 | +8.9% | 653,448 | 0.0% | 0.49% | +51.2% | |
INSM | New | INSMED INC | $2,465,000 | – | 125,000 | +100.0% | 0.45% | – |
VKTX | Buy | VIKING THERAPEUTICS INC | $2,414,000 | +51.3% | 835,275 | +56.9% | 0.44% | +109.5% |
ATHA | ATHIRA PHARMA INCcall | $2,393,000 | -77.4% | 784,200 | 0.0% | 0.44% | -68.7% | |
ISEE | New | IVERIC BIO INCcall | $2,351,000 | – | 244,400 | +100.0% | 0.43% | – |
COGT | New | COGENT BIOSCIENCES INC | $2,256,000 | – | 250,000 | +100.0% | 0.41% | – |
ACET | Sell | ADICET BIO INC | $2,091,000 | -79.4% | 143,214 | -71.8% | 0.38% | -71.4% |
ITOS | New | ITEOS THERAPEUTICS INCcall | $2,061,000 | – | 100,000 | +100.0% | 0.38% | – |
LYRA | Sell | LYRA THERAPEUTICS INC | $1,963,000 | +15.6% | 347,338 | -17.8% | 0.36% | +60.5% |
APLS | New | APELLIS PHARMACEUTICALS INC | $1,894,000 | – | 41,900 | +100.0% | 0.34% | – |
SRPT | New | SAREPTA THERAPEUTICS INC | $1,874,000 | – | 25,000 | +100.0% | 0.34% | – |
MCRB | Sell | SERES THERAPEUTICS INC | $1,854,000 | -69.0% | 540,624 | -35.7% | 0.34% | -57.1% |
BBIO | New | BRIDGEBIO PHARMA INCcall | $1,817,000 | – | 200,000 | +100.0% | 0.33% | – |
Buy | ASTRIA THERAPEUTICS INC | $1,776,000 | +186.9% | 592,123 | +542.1% | 0.32% | +300.0% | |
TERN | New | TERNS PHARMACEUTICALS INC | $1,736,000 | – | 700,000 | +100.0% | 0.32% | – |
XFOR | Buy | X4 PHARMACEUTICALS INC | $1,621,000 | -32.5% | 1,679,748 | +22.4% | 0.30% | -6.3% |
ALDX | ALDEYRA THERAPEUTICS INC | $1,496,000 | -10.3% | 375,000 | 0.0% | 0.27% | +24.7% | |
ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $1,449,000 | +153.3% | 105,000 | +198.7% | 0.26% | +252.0% |
DBVT | DBV TECHNOLOGIES S Asponsored adr | $1,401,000 | +33.8% | 316,939 | 0.0% | 0.26% | +84.8% | |
IMTX | Sell | IMMATICS N.V | $1,369,000 | -78.1% | 157,190 | -79.9% | 0.25% | -69.5% |
VBLT | Sell | VASCULAR BIOGENICS LTD | $1,337,000 | -4.8% | 830,007 | -0.1% | 0.24% | +31.9% |
Buy | AADI BIOSCIENCE INC | $1,274,000 | -64.0% | 412,343 | +97.9% | 0.23% | -50.1% | |
RCUS | New | ARCUS BIOSCIENCES INCput | $1,266,000 | – | 50,000 | +100.0% | 0.23% | – |
MIST | New | MILESTONE PHARMACEUTICALS INcall | $1,261,000 | – | 212,400 | +100.0% | 0.23% | – |
MRUS | MERUS N V | $1,216,000 | -14.4% | 53,703 | 0.0% | 0.22% | +18.7% | |
CABA | Sell | CABALETTA BIO INC | $1,000,000 | -51.7% | 944,431 | -7.4% | 0.18% | -33.1% |
CMMB | CHEMOMAB THERAPEUTICS LTDsponsored ads | $992,000 | -23.2% | 268,104 | 0.0% | 0.18% | +6.5% | |
ARDX | New | ARDELYX INC | $991,000 | – | 1,680,552 | +100.0% | 0.18% | – |
ANEB | ANEBULO PHARMACEUTICALS INC | $942,000 | -23.1% | 181,199 | 0.0% | 0.17% | +6.8% | |
FNCH | FINCH THERAPEUTICS GROUP INC | $938,000 | -43.6% | 330,523 | 0.0% | 0.17% | -21.9% | |
BLU | New | BELLUS HEALTH INC NEWcall | $924,000 | – | 100,000 | +100.0% | 0.17% | – |
CMRX | Sell | CHIMERIX INC | $917,000 | -76.2% | 441,203 | -47.6% | 0.17% | -67.1% |
AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $912,000 | -41.2% | 322,217 | -13.4% | 0.17% | -18.6% |
TCDA | TRICIDA INCput | $899,000 | +17.7% | 92,900 | 0.0% | 0.16% | +64.0% | |
FULC | New | FULCRUM THERAPEUTICS INCcall | $893,000 | – | 182,200 | +100.0% | 0.16% | – |
ELDN | ELEDON PHARMACEUTICALS INC | $884,000 | -38.1% | 362,537 | 0.0% | 0.16% | -14.4% | |
RIGL | Sell | RIGEL PHARMACEUTICALS INC | $794,000 | -87.6% | 702,773 | -67.1% | 0.14% | -82.7% |
CLVS | Sell | CLOVIS ONCOLOGY INC | $761,000 | -51.2% | 422,339 | -45.3% | 0.14% | -32.2% |
AYLA | Sell | AYALA PHARMACEUTICALS INC | $759,000 | -73.1% | 697,316 | -1.6% | 0.14% | -62.8% |
TARA | Sell | PROTARA THERAPEUTICS INC | $756,000 | -50.1% | 257,853 | -13.0% | 0.14% | -30.7% |
ALRN | Sell | AILERON THERAPEUTICS INC | $752,000 | -49.4% | 2,892,316 | -0.3% | 0.14% | -30.1% |
GMTX | GEMINI THERAPEUTICS INC | $749,000 | +21.8% | 443,096 | 0.0% | 0.14% | +69.1% | |
BCLI | Sell | BRAINSTORM CELL THERAPEUTICS | $698,000 | -31.7% | 253,432 | -16.7% | 0.13% | -5.2% |
Sell | PARDES BIOSCIENCES INC | $687,000 | -70.6% | 223,934 | -30.9% | 0.12% | -59.3% | |
RETA | Sell | REATA PHARMACEUTICALS INCcl a | $632,000 | -77.8% | 20,805 | -76.1% | 0.12% | -69.3% |
BELLICUM PHARMACEUTICALS INC | $617,000 | -45.4% | 523,348 | 0.0% | 0.11% | -24.2% | ||
CFRX | New | CONTRAFECT CORPput | $615,000 | – | 200,000 | +100.0% | 0.11% | – |
SNPX | Sell | SYNAPTOGENIX INC | $614,000 | -48.2% | 121,191 | -20.9% | 0.11% | -28.2% |
ATHA | Sell | ATHIRA PHARMA INCput | $609,000 | -77.4% | 199,500 | -0.2% | 0.11% | -68.7% |
Sell | RENOVACOR INC | $595,000 | -59.1% | 293,283 | -14.6% | 0.11% | -43.5% | |
CNTB | CONNECT BIOPHARMA HLDGS LTDads | $591,000 | -71.1% | 677,859 | 0.0% | 0.11% | -59.9% | |
RCUS | Sell | ARCUS BIOSCIENCES INCcall | $588,000 | -87.6% | 23,200 | -84.5% | 0.11% | -82.8% |
INBX | Sell | INHIBRX INC | $561,000 | -84.0% | 49,372 | -68.7% | 0.10% | -77.9% |
SYBX | Sell | SYNLOGIC INC | $545,000 | -56.3% | 474,360 | -8.7% | 0.10% | -39.6% |
EOLS | New | EVOLUS INC | $529,000 | – | 45,516 | +100.0% | 0.10% | – |
RPHM | RENEO PHARMACEUTICALS INC | $491,000 | -10.1% | 185,597 | 0.0% | 0.09% | +25.0% | |
ISEE | IVERIC BIO INC | $473,000 | -42.7% | 49,099 | 0.0% | 0.09% | -20.4% | |
New | CASI PHARMACEUTICALS INC | $378,000 | – | 132,014 | +100.0% | 0.07% | – | |
NXTC | Sell | NEXTCURE INC | $336,000 | -51.0% | 71,435 | -49.4% | 0.06% | -32.2% |
WVE | Sell | WAVE LIFE SCIENCES LTD | $318,000 | -84.8% | 98,039 | -90.6% | 0.06% | -78.9% |
ZLAB | ZAI LAB LTDadr | $278,000 | -26.1% | 81,843 | 0.0% | 0.05% | +4.1% | |
VSTM | Sell | VERASTEM INC | $265,000 | -72.3% | 228,023 | -66.4% | 0.05% | -61.9% |
PRAX | New | PRAXIS PRECISION MEDICINES Icall | $263,000 | – | 107,200 | +100.0% | 0.05% | – |
IPA | Sell | IMMUNOPRECISE ANTIBODIES LTD | $237,000 | -40.6% | 61,433 | -20.9% | 0.04% | -17.3% |
HEPA | Sell | HEPION PHARMACEUTICALS INC | $235,000 | -68.7% | 410,189 | -29.5% | 0.04% | -56.6% |
BIIB | BIOGEN INC | $228,000 | -3.8% | 1,122 | 0.0% | 0.04% | +35.5% | |
New | REGULUS THERAPEUTICS INC | $217,000 | – | 105,341 | +100.0% | 0.04% | – | |
CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $217,000 | -59.1% | 862,527 | -13.5% | 0.04% | -42.9% |
IMUX | New | IMMUNIC INC | $214,000 | – | 61,500 | +100.0% | 0.04% | – |
IMUX | IMMUNIC INCput | $213,000 | -69.4% | 61,500 | 0.0% | 0.04% | -57.6% | |
MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $199,000 | -37.4% | 615,856 | -32.8% | 0.04% | -14.3% |
VRNA | New | VERONA PHARMA PLCsponsored ads | $200,000 | – | 300,000 | +100.0% | 0.04% | – |
YMTX | Sell | YUMANITY THERAPEUTICS INC | $190,000 | -46.5% | 104,392 | -55.8% | 0.04% | -25.5% |
ASLN | ASLAN PHARMACEUTICALS LTDads | $185,000 | -3.6% | 970,747 | 0.0% | 0.03% | +36.0% | |
CLNN | Sell | CLENE INC | $177,000 | -91.3% | 70,000 | -86.4% | 0.03% | -88.0% |
Sell | MYMD PHARMACEUTICALS INC | $176,000 | -71.2% | 81,089 | -38.3% | 0.03% | -60.0% | |
MBIO | Sell | MUSTANG BIO INC | $145,000 | -73.7% | 246,824 | -54.9% | 0.03% | -63.9% |
TPST | TEMPEST THERAPEUTICS INC | $132,000 | -37.1% | 61,827 | 0.0% | 0.02% | -14.3% | |
MITO | STEALTH BIOTHERAPEUTICS CORPsponsored ads | $127,000 | -63.7% | 501,836 | 0.0% | 0.02% | -50.0% | |
CYCC | CYCLACEL PHARMACEUTICALS INC | $113,000 | -64.6% | 104,741 | 0.0% | 0.02% | -50.0% | |
LRMR | LARIMAR THERAPEUTICS INC | $100,000 | -52.2% | 51,606 | 0.0% | 0.02% | -33.3% | |
IVA | INVENTIVA SAads | $93,000 | -47.8% | 15,579 | 0.0% | 0.02% | -26.1% | |
BRIGHT MINDS BIOSCIENCES INC | $86,000 | -46.6% | 105,958 | 0.0% | 0.02% | -23.8% | ||
MNMD | MIND MEDICINE MINDMED INC | $68,000 | -42.4% | 105,958 | 0.0% | 0.01% | -25.0% | |
OVID | Sell | OVID THERAPEUTICS INC | $59,000 | -97.5% | 26,831 | -96.4% | 0.01% | -96.4% |
ENVB | Sell | ENVERIC BIOSCIENCES INC | $48,000 | -66.0% | 223,834 | -47.2% | 0.01% | -52.6% |
Sell | ALTAMIRA THERAPEUTICS LTD | $36,000 | -89.7% | 75,000 | -76.6% | 0.01% | -84.8% | |
BAUDAX BIO INC | $3,000 | -25.0% | 2,966 | 0.0% | 0.00% | 0.0% | ||
BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -306 | -100.0% | 0.00% | – |
OTIC | Sell | OTONOMY INC | $0 | -100.0% | 180 | -99.9% | 0.00% | -100.0% |
KDNY | New | CHINOOK THERAPEUTICS INC | $0 | – | 332,295 | +100.0% | 0.00% | – |
Exit | 2SEVENTY BIO INC | $0 | – | -99 | -100.0% | 0.00% | – | |
KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -830 | -100.0% | -0.00% | – |
KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -1,990 | -100.0% | -0.00% | – |
PDSB | Exit | PDS BIOTECHNOLOGY CORP | $0 | – | -3,672 | -100.0% | -0.00% | – |
TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -2,292 | -100.0% | -0.00% | – |
SLNO | Exit | SOLENO THERAPEUTICS INC | $0 | – | -128,454 | -100.0% | -0.00% | – |
ONTX | Exit | ONCONOVA THERAPEUTICS INC | $0 | – | -18,975 | -100.0% | -0.01% | – |
Exit | TANGO THERAPEUTICS INC | $0 | – | -5,456 | -100.0% | -0.01% | – | |
IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -1,587 | -100.0% | -0.01% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,882 | -100.0% | -0.01% | – |
AMYT | Exit | AMRYT PHARMA PLCsponsored ads | $0 | – | -37,248 | -100.0% | -0.01% | – |
ATNX | Exit | ATHENEX INC | $0 | – | -80,039 | -100.0% | -0.01% | – |
NVAX | Exit | NOVAVAX INC | $0 | – | -1,362 | -100.0% | -0.01% | – |
CMPX | Exit | COMPASS THERAPEUTICS INC | $0 | – | -74,171 | -100.0% | -0.01% | – |
ORTX | Exit | ORCHARD THERAPEUTICS PLCads | $0 | – | -155,606 | -100.0% | -0.01% | – |
BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -5,428 | -100.0% | -0.02% | – |
GOSS | Exit | GOSSAMER BIO INCput | $0 | – | -14,900 | -100.0% | -0.02% | – |
GMDA | Exit | GAMIDA CELL LTD | $0 | – | -32,689 | -100.0% | -0.02% | – |
Exit | APTOSE BIOSCIENCES INC | $0 | – | -106,952 | -100.0% | -0.02% | – | |
PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -49,843 | -100.0% | -0.02% | – |
OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -29,644 | -100.0% | -0.02% | – |
KOD | Exit | KODIAK SCIENCES INCcall | $0 | – | -25,700 | -100.0% | -0.03% | – |
LIFE | Exit | ATYR PHARMA INC | $0 | – | -37,017 | -100.0% | -0.03% | – |
ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -12,124 | -100.0% | -0.03% | – |
SEEL | Exit | SEELOS THERAPEUTICS INC | $0 | – | -257,883 | -100.0% | -0.03% | – |
PASG | Exit | PASSAGE BIO INC | $0 | – | -71,856 | -100.0% | -0.03% | – |
GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -206,336 | -100.0% | -0.03% | – |
AGEN | Exit | AGENUS INC | $0 | – | -108,933 | -100.0% | -0.04% | – |
EYPT | Exit | EYEPOINT PHARMACEUTICALS INC | $0 | – | -22,552 | -100.0% | -0.04% | – |
ONCT | Exit | ONCTERNAL THERAPEUTICS INC | $0 | – | -210,182 | -100.0% | -0.04% | – |
CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -476,625 | -100.0% | -0.04% | – |
CDAK | Exit | CODIAK BIOSCIENCES INC | $0 | – | -52,177 | -100.0% | -0.04% | – |
FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -9,640 | -100.0% | -0.05% | – |
RGLS | Exit | REGULUS THERAPEUTICS INC | $0 | – | -1,289,130 | -100.0% | -0.05% | – |
VLON | Exit | VALLON PHARMACEUTICALS INC | $0 | – | -201,758 | -100.0% | -0.05% | – |
Exit | NEUROSENSE THERAPEUTICS LTDordinary shares | $0 | – | -100,000 | -100.0% | -0.05% | – | |
OCUP | Exit | OCUPHIRE PHARMA INC | $0 | – | -124,021 | -100.0% | -0.05% | – |
BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -159,390 | -100.0% | -0.06% | – |
AGTC | Exit | APPLIED GENETIC TECHNOLOGIES | $0 | – | -412,293 | -100.0% | -0.06% | – |
ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -227,076 | -100.0% | -0.06% | – |
KOD | Exit | KODIAK SCIENCES INC | $0 | – | -68,100 | -100.0% | -0.07% | – |
VTVT | Exit | VTV THERAPEUTICS INCcl a | $0 | – | -742,980 | -100.0% | -0.07% | – |
DMAC | Exit | DIAMEDICA THERAPEUTICS INC | $0 | – | -221,252 | -100.0% | -0.07% | – |
Exit | AVALO THERAPEUTICS INC | $0 | – | -764,271 | -100.0% | -0.07% | – | |
KOD | Exit | KODIAK SCIENCES INCput | $0 | – | -73,100 | -100.0% | -0.07% | – |
AKBA | Exit | AKEBIA THERAPEUTICS INCcall | $0 | – | -800,000 | -100.0% | -0.08% | – |
RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -21,801 | -100.0% | -0.08% | – |
KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -39,730 | -100.0% | -0.08% | – |
CYCN | Exit | CYCLERION THERAPEUTICS INC | $0 | – | -527,462 | -100.0% | -0.08% | – |
HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -117,009 | -100.0% | -0.08% | – |
Exit | TENAX THERAPEUTICS INC | $0 | – | -735,097 | -100.0% | -0.08% | – | |
SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -521,155 | -100.0% | -0.08% | – |
VTGN | Exit | VISTAGEN THERAPEUTICS INC | $0 | – | -511,186 | -100.0% | -0.08% | – |
PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -90,805 | -100.0% | -0.08% | – |
IFRX | Exit | INFLARX NV | $0 | – | -349,468 | -100.0% | -0.08% | – |
NKTR | Exit | NEKTAR THERAPEUTICScall | $0 | – | -133,900 | -100.0% | -0.10% | – |
QSI | Exit | QUANTUM SI INC | $0 | – | -157,363 | -100.0% | -0.10% | – |
PBLA | Exit | PANBELA THERAPEUTICS INC | $0 | – | -355,959 | -100.0% | -0.10% | – |
BLSA | Exit | BCLS ACQUISITION CORP | $0 | – | -77,274 | -100.0% | -0.10% | – |
CRVS | Exit | CORVUS PHARMACEUTICALS INC | $0 | – | -510,126 | -100.0% | -0.11% | – |
AKBA | Exit | AKEBIA THERAPEUTICS INCput | $0 | – | -1,200,000 | -100.0% | -0.11% | – |
CABA | Exit | CABALETTA BIO INCcall | $0 | – | -449,000 | -100.0% | -0.12% | – |
Exit | MAXCYTE INC | $0 | – | -137,958 | -100.0% | -0.13% | – | |
ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -8,763 | -100.0% | -0.14% | – |
CASI | Exit | CASI PHARMACEUTICALS INC | $0 | – | -1,320,155 | -100.0% | -0.14% | – |
PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -78,550 | -100.0% | -0.14% | – |
AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -87,071 | -100.0% | -0.14% | – |
NUVB | Exit | NUVATION BIO INC | $0 | – | -213,310 | -100.0% | -0.15% | – |
ACET | Exit | ADICET BIO INCcall | $0 | – | -62,100 | -100.0% | -0.16% | – |
MGNX | Exit | MACROGENICS INC | $0 | – | -164,119 | -100.0% | -0.19% | – |
GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -49,997 | -100.0% | -0.23% | – |
LQDA | Exit | LIQUIDIA CORPORATION | $0 | – | -243,904 | -100.0% | -0.23% | – |
INBX | Exit | INHIBRX INCcall | $0 | – | -85,800 | -100.0% | -0.25% | – |
PMVP | Exit | PMV PHARMACEUTICALS INCput | $0 | – | -100,000 | -100.0% | -0.27% | – |
PMVP | Exit | PMV PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.27% | – |
KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.28% | – |
SVRA | Exit | SAVARA INC | $0 | – | -1,622,552 | -100.0% | -0.28% | – |
ZLAB | Exit | ZAI LAB LTDcall | $0 | – | -53,100 | -100.0% | -0.31% | – |
NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -47,408 | -100.0% | -0.45% | – |
PTGX | Exit | PROTAGONIST THERAPEUTICS INCcall | $0 | – | -160,700 | -100.0% | -0.50% | – |
BCYC | Exit | BICYCLE THERAPEUTICS PLCput | $0 | – | -106,600 | -100.0% | -0.62% | – |
AMGN | Exit | AMGEN INC | $0 | – | -20,000 | -100.0% | -0.64% | – |
SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -217,915 | -100.0% | -0.92% | – |
BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -60,000 | -100.0% | -0.94% | – |
SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -249,907 | -100.0% | -1.09% | – |
ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -202,203 | -100.0% | -1.23% | – |
GILD | Exit | GILEAD SCIENCES INCput | $0 | – | -181,300 | -100.0% | -1.42% | – |
GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -181,300 | -100.0% | -1.42% | – |
BCYC | Exit | BICYCLE THERAPEUTICS PLCcall | $0 | – | -264,700 | -100.0% | -1.53% | – |
UTHR | Exit | UNITED THERAPEUTICS CORP DELcall | $0 | – | -100,000 | -100.0% | -2.36% | – |
BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -478,784 | -100.0% | -2.76% | – |
RETA | Exit | REATA PHARMACEUTICALS INCput | $0 | – | -649,600 | -100.0% | -2.80% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES INCcall | $0 | – | -429,600 | -100.0% | -5.30% | – |
XBI | Exit | SPDR SER TRcall | $0 | – | -935,600 | -100.0% | -11.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
SPDR SER TR | 13 | Q3 2023 | 9.0% |
VAXCYTE INC | 13 | Q3 2023 | 2.9% |
TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-04-05 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.